Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Anticoagulation Treatment" patented technology

Anticoagulation Therapy. Your healthcare provider may have prescribed an anticoagulant, also known as a “blood thinner” medication, such as Warfarin (Coumadin®), to treat or prevent a serious blood clot condition. A healthcare provider referral is required for Anticoagulation Therapy.

Method for extracting modified plasma protein powder and bioactive peptide for enriching blood from pig blood

The invention discloses a method for extracting modified plasma protein powder and bioactive peptide for enriching blood from pig blood, comprising the following steps of: taking fresh and healthy pig blood as a raw material; carrying out anticoagulation treatment, centrifuging and separation on the fresh and healthy pig blood to obtain a blood cell and blood plasma; carrying out high-pressure cutting and wall breaking, complex enzyme hydrolysis and flashing and deodorizing process treatment on the blood cell to obtain enzymolysis liquid; carrying out rough filtration, fine filtration, condensation treatment and spray drying to obtain the bioactive peptide for enriching the blood; and carrying out modification treatment on the separated blood plasma to obtain the plasma protein powder. The invention has the following advantages that: 1. the production cost is low and no pollution to the environment is generated; 2. the average molecular weight of small peptide of the produced bioactive peptide for enriching the blood is not more than 10,000Dalton, the content of free amino acid is not more than 15.0percent and the protein of the plasma protein powder is not less than 90.0 percent; 3. the water content of the produced modified plasma protein is not more than 5.0 percent, the viscosity (5 percent solution) is not less than 2.0 mpa.s and the content of the protein is not less than 90.0 percent; and 4. the process method saves time and energy, has simple operation and fully utilizes pig blood resources.
Owner:天津市食品工业生产力促进中心

Method for extracting hemin and globin from animal blood

The invention relates to a method for extracting hemin and globin by the use of leech protease with animal blood as a raw material. The method comprises the following main steps of: 1, carrying out middle-temperature extraction to prepare leech protease for later use; 2, taking fresh animal blood, carrying out anticoagulation treatment, centrifuging and collecting hemoglobin cells; 3, adding one time of pure water, carrying out ultrasonic treatment and breaking cells; 4, filtering through a screen mesh, leaving a filtrate, and adjusting pH value; 5, adding leech protease for enzymatic hydrolysis; 6, adjusting pH value of an enzymatic hydrolysis liquid and carrying out centrifugal separation; and 7, washing a sediment which has undergone centrifugation, carrying out dehydrolysis and drying to obtain hemin; letting a supernatant which has undergone centrifugation pass through a microfiltration membrane to remove impurities, using a nanofiltration membrane for concentration, and carrying out dehydrolysis and drying on a concentrate to obtain globin. According to the invention, animal blood resources are fully utilized and the leech extract product is used as an enzyme preparation to produce hemin and globin with high added values. The technology is simple and easy to operate, the production cost is low, and the method is suitable for industrial production.
Owner:武汉普赛特膜技术循环利用有限公司

Medical care interaction system for preventing and treating venous thromboembolism of inpatients

PendingCN110556186AReduce morbidityReduce the incidence of fatal VTEMedical communicationHealthcare resources and facilitiesInteraction systemsPrevention intervention
The invention discloses a medical care interaction system for preventing and treating venous thromboembolism of inpatients. The system is composed of a patient scoring system, a patient risk estimation system, a patient prevention intervention operation system, a patient informed agreement signing system and a background data capturing system. The patient scoring system outputs data to the patientrisk estimation system; the patient risk estimation system outputs data to the patient prevention intervention operation system, the patient prevention intervention operation system receives the dataand then presents the data to a doctor, the output end of the patient prevention intervention operation system is connected with the input end of the patient informed agreement signing system, and the background data capture system captures nursing evaluation information and doctor intervention information. The VTE morbidity of inpatients is effectively reduced, the important indexes such as theVTE risk assessment rate, the preventive measure implementation rate, the ratio of implementing anticoagulation treatment on the inpatients, the VTE detection rate and the hospital related lethal VTEoccurrence rate are focused on, and the social benefits and economic benefits of VTE prevention and treatment are remarkably improved.
Owner:田红燕

Preparation method for producing pig haemocyte active small peptide powder through one-step method

The invention relates to a preparation method for producing pig haemocyte active small peptide powder through a one-step method. The preparation method mainly comprises the steps of collecting fresh pig blood subjected to anticoagulation treatment, conducting centrifugal separation to obtain haemocyte liquid, conducting hemolysis, enzymolysis and centrifugation to obtain enzymatic hydrolysate, conducting ultrafiltration membrane filtration and nanofiltration membrane concentration on the enzymatic hydrolysate, and then conducting spray drying, so that the pig haemocyte active small peptide powder is obtained. According to the preparation method, efficient endo protease is selected, the one-step method is adopted, the ultrafiltration membrane and nanofiltration membrane separation technology is combined, the process procedure is simple, the production cycle is short, production efficiency is high, cost is low, and the preparation method is suitable for large-scale industrialized production. In the prepared pig haemocyte active small peptide powder, the content of active small peptide (with the relative molecular weight ranging from 180 Da to 1000 Da) reaches 75% or above, the content of organic hemin (heme iron) reaches 0.2% or above, the content of ash is lower than 5.0%, and the content of free amino acid is lower than 11%. The product can promote growth of animals and enhance immunity and disease resistance of animals and is a novel functional protein feed raw material.
Owner:陈石良

Processing method of flavored sheep/goat lung crisp chips

The invention discloses a processing method of flavored sheep / goat lung crisp chips. Through anticoagulation treatment, bloodstain in blood vessels of sheep / goat lung is effectively eliminated, the color of the sheep / goat lung is maintained to be bright, the putrid and deteriorated process of the sheep / goat lung is alleviated, and blood smell is eliminated; through technologies of alkaline washingand kneading, ultrasonic vibration, rinsing and dehydration and the like, endocrine substances and metabolism dirt of lung tracheas are thoroughly eliminated, sheep / goat odor is removed to the maximum extent, and peculiar smell of the sheep / goat lung is reduced; and unique flavor of steamed eel in black bean sauce is creatively used as seasoning, and the flavor feature of the sheep / goat lung crisp chips is improved. According to the processing method disclosed by the invention, on the base of creating a washing technology and reinforcing sheep / goat odor eliminating effects, the unique flavorof the steamed eel in black bean sauce is utilized as the seasoning, so that the sheep / goat odor is better covered, the individual flavor feature of the sheep / goat lung crisp chips is increased, new snack foods in great demand namely the sheep lung crisp chips are created, and high-value development of sheep / goat entrails is realized.
Owner:JIESHOU JINGHUA TECH INFORMATION CONSULTING SERVICE CO LTD

Kit for detecting functions of coagulation and platelets of heparin-added blood samples and application thereof

PendingCN107746804ATimely point-of-care coagulation assessmentAccurate point-of-care coagulation assessmentBioreactor/fermenter combinationsBiological substance pretreatmentsDiseaseThrombus
The invention provides a kit for detecting functions of coagulation and platelets of heparin-added blood samples and application thereof and relates to the technical field of medical apparatus and instruments. The detection kit comprises a reagent cup and a detection probe, wherein glass beads and a stirring rod are arranged in the reagent cup; the reagent cup also comprises a cup lid; the reagentcup is tightly bonded with the cup lid; a groove is formed in the center of the cup lid and is used for mounting the detection probe; heparinase I is arranged in the reagent cup. The detection kit takes the glass beads as activators, is capable of detecting the functions of coagulation and platelets of heparin-added blood samples through an in-vitro coagulation activating method, has great significance to early discovery of the risk of thrombosis of patients, guidance of anticoagulation treatment and component blood transfusion, and diagnosis and treatment of platelet-related diseases, and iscapable of making up the defects of detection of the functions of coagulation and platelets of the heparin-added human blood in the in-vitro study field at present.
Owner:世纪亿康(天津)医疗科技发展有限公司

Application of circulating tfpi-2 (tissue factor pathway inhibitor 2) in the assessment of atrial fibrillation and anticoagulation therapy

The present invention relates to a method for assessing atrial fibrillation in a subject, said method comprising the steps of determining the amount of TFPI-2 in a sample from the subject, and comparing the amount of TFPI-2 to a reference amount, whereby atrial fibrillation is to be assessed. Moreover, the present invention relates to methods for assessing anticoagulation therapy and to methods for predicting the risk of stroke of a subject. Said methods are based on the determination of the amount of TFPI-2 in a sample from the subject.
Owner:F HOFFMANN LA ROCHE & CO AG +2

Model for predicting rivaroxaban anticoagulation bleeding risk and application thereof

The invention discloses a model for predicting the anti-coagulation bleeding risk of rivaroxaban and application of the model, and belongs to the technical field of biological detection. The model comprises a data input unit, an assignment unit, a curative effect prediction unit and a report output unit for two independent risk factors of a CYP3A4 genotype and a clinical bleeding history of a detected object, and a Camp is formed according to the units; b, the scoring system is used for counting according to the total score of 3, if Camp; the score B is less than or equal to 1, and rivaroxaban can be used as a blood coagulation factor X inhibitor for anticoagulation treatment; if Camp; the score B is greater than or equal to 2, and warfarin can be selected for anticoagulation treatment. The model can be used for guiding a clinician to accurately select a blood coagulation factor X inhibitor, a rivaroxaban bleeding risk prediction result is accurate and reliable, and a balance can be obtained between anticoagulation benefit and bleeding risk.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Method for extracting hemin and globin from animal blood

The invention relates to a method for extracting hemin and globin by the use of leech protease with animal blood as a raw material. The method comprises the following main steps of: 1, carrying out middle-temperature extraction to prepare leech protease for later use; 2, taking fresh animal blood, carrying out anticoagulation treatment, centrifuging and collecting hemoglobin cells; 3, adding one time of pure water, carrying out ultrasonic treatment and breaking cells; 4, filtering through a screen mesh, leaving a filtrate, and adjusting pH value; 5, adding leech protease for enzymatic hydrolysis; 6, adjusting pH value of an enzymatic hydrolysis liquid and carrying out centrifugal separation; and 7, washing a sediment which has undergone centrifugation, carrying out dehydrolysis and drying to obtain hemin; letting a supernatant which has undergone centrifugation pass through a microfiltration membrane to remove impurities, using a nanofiltration membrane for concentration, and carrying out dehydrolysis and drying on a concentrate to obtain globin. According to the invention, animal blood resources are fully utilized and the leech extract product is used as an enzyme preparation to produce hemin and globin with high added values. The technology is simple and easy to operate, the production cost is low, and the method is suitable for industrial production.
Owner:武汉普赛特膜技术循环利用有限公司

Preparation method of sheep peripheral blood lymphocyte transfer factor solution and injection

The invention provides a preparation method of a sheep peripheral blood lymphocyte transfer factor solution, which comprises the following steps: collecting fresh sheep blood, carrying out anticoagulation treatment, and carrying out cell sedimentation and separation; collecting a lymphocyte layer, and diluting the collected lymphocytes with Hank's liquid to prepare a lymphocyte seed suspension for later use; performing cell suspension culture on the lymphocyte seed suspension to obtain lymphocyte liquid; the lymphocyte fluid is subjected to cell disruption, the disrupted cells are filtered and ultra-filtered through a microfiltration membrane and an ultra-filtration membrane respectively, and ultra-filtrate is the obtained transfer factor solution; the invention also provides an injection which is prepared by performing sterile filtration on a transfer factor solution and then adding mannitol and normal saline. According to the method, sheep leukocytes are used as a culture medium, a cell suspension culture process is adopted for enlarged culture, the prepared transfer factor solution, namely the injection, can be suitable for large-scale production, and the yield is greatly improved.
Owner:商丘美兰生物工程有限公司

Traditional Chinese medicine composition for treating long-term anticoagulation for patients with atrial fibrillation and preparation method thereof

The invention discloses a traditional Chinese medicine composition for treating long-term anticoagulation for patients with atrial fibrillation and a preparation method of the traditional Chinese medicine composition, and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from the following raw medicinal materials in parts by weight: 10-20 parts of Chinese angelica, 10-20 parts of peach kernels, 15-45 parts of safflowers, 10-20 parts of trichosanthes, 10-20 parts of bitter oranges, 10-20 parts of twotooth achyranthes roots, 2-9 parts of sanchi, 5-15 parts of platycodon grandiflorum, 5-15 parts of tangerine peels, 5-15 parts of red peony, 10-20 parts of Chinese thorowax roots and 3-5 parts of dragon blood. An experiment proves that the traditional Chinese medicine composition can be used for preventing or treating atrial fibrillation, especially severe bleeding complications which are caused during prevention treatment of atrial fibrillation anticoagulation; meanwhile, the composition also has the characteristics of activating blood and removing stasis and inspiring vital energy and blood, and is mild in drug properties, and warm heat and dryness heat are avoided; the pathological factors such as vascular endothelial injury and intravascular vortex formation can be effectively corrected, and the prognosis of large vascular restenosis and occlusion can be improved.
Owner:周辉

Preparation method and application for oral solution containing Panax ginseng, Codonopsis pilosula, radix scrophulariae, radix ginseng Rubra, radix salviae miltiorrhizae and astragalus membranaceus

The invention discloses a preparation method and an application for an oral solution containing Panax ginseng, Codonopsis pilosula, radix scrophulariae, radix ginseng Rubra, radix salviae miltiorrhizae and astragalus membranaceus. The preparation method for porcine protein-free serum comprises the following steps: taking pig blood for anticoagulation treatment and denaturation treatment, and collecting a first filtrate; concentrating the first filtrate so as to obtain a first concentrate, carrying out centrifuging, allowing a supernate to flowing into a column mixing bed, collecting an effluent liquid, and carrying out filtering so as to obtain a second filtrate; allowing the second filtrate to flow through an ultrafiltration column, and collecting a permeate; and concentrating the permeate so as to obtain a second concentrate, adding medicinal active carbon, carrying out adsorption treatment, carrying out heating to 80 DEG C, carrying out filtering, blending the filtrate, filling thefiltrate into an oral liquid bottle, carrying out sealing and sterilizing, and carrying out storing in a shade place. The porcine protein-free serum obtained by using the preparation method provided by the invention reaches a dry matter content and a trace element content respectively up to 75.1% and 0.092%, and has trace elements with a content higher than the average level of the trace elementscontained in human serum. The porcine protein-free serum provided by the invention is used for preparing the oral solution containing Panax ginseng, Codonopsis pilosula, radix scrophulariae, radix ginseng Rubra, radix salviae miltiorrhizae and astragalus membranaceus, and has obvious treatment effects on gastric ulcer and duodenal ulcer.
Owner:HUBEI WEISHI BIO PHARMA

A kind of preparation method of Wushenqi oral solution and application thereof

The invention discloses a preparation method and application of Wushenqi oral solution. The preparation method of the pig protein-free serum comprises: taking pig blood for anticoagulant treatment and denaturation treatment, collecting the first filtrate; the first filtrate is concentrated to obtain the first concentrated solution, and after centrifugation, the supernatant is taken to flow through the column mixed bed, and the effluent is collected. Liquid, filtered to obtain the second filtrate; flow the second filtrate through the ultrafiltration column to collect the permeate; concentrate the permeate to obtain the second concentrate, add pharmaceutical grade activated carbon for adsorption treatment, heat up to 80 °C and filter, the filtrate is passed through After preparation, fill it into an oral liquid bottle and seal it, and store it in a cool place after sterilization. The pig protein-free serum obtained by the preparation method of the invention has dry matter content and trace element content as high as 75.1% and 0.092% respectively, and the trace element content is higher than the average level of trace element contained in human serum. The Wushenqi oral solution prepared by the pig protein-free serum provided by the invention has obvious therapeutic effects on gastric and duodenal ulcers.
Owner:HUBEI WEISHI BIO PHARMA

Method for sorting human marrow very small embryonic-like stem cells

The invention belongs to a method for sorting human marrow very small embryonic-like stem cells, which comprises the following steps: under a constant temperature of 4 DEGC, adding 30 milliliters of erythrocyte lysing solution into 10 milliliters of human marrow which is subjected to anticoagulation treatment by heparin saline, uniformly mixing, performing centrifugal separation for 10 minutes, removing supernate, adding 20 milliliters of erythrocyte lysing solution into 10 milliliters of sediment, uniformly mixing, performing centrifugal separation for 10 minutes, removing supernate, obtaining secondary sediment, washing with ethylene diamine tetraacetic acid (EDTA) buffer solution under a condition of 4 DEG C, and obtaining cell suspension; and filtering the cell suspension with 30-micrometer meshes, subjecting the filtrate to centrifugal separation at 4 DEG C for 5 minutes, removing supernate, adding the sediment into the EDTA buffer solution till the volume is 300 to 310 microliter, and obtaining re-suspended cell solution; and performing negative sorting and positive sorting. The method has the advantages of protecting the integrity of very small embryonic-like stem cells, simplifying sorting flow, reducing sorting time, achieving high recovery rate, along with simplicity, practicality and low extraction cost.
Owner:杨跃进 +1

Method and device for extracting platelet-rich plasma from blood

The invention relates to a method and device for extracting platelet-rich plasma from blood. The method comprises the steps that a conical head of a first injector containing blood subjected to anticoagulation treatment faces downwards, the first injector is centrifuged for 5-45 minutes at the relative centrifugal force of 300-3000 g, and the content in the first injector is divided into a platelet-poor plasma layer, a platelet-rich plasma layer and a red blood cell layer from top to bottom; the conical head of the first injector is kept downward, and the red blood cell layer in the first injector is transferred into a collecting container through a communicating piece; the conical head of the first injector is kept downward, and the platelet-rich plasma layer in the first injector is transferred into the second injector through the communicating piece, so that only the platelet-rich plasma layer is contained in the second injector; and the platelet-rich plasma in the second injector and the blood coagulation agent in the third injector transferred to a spraying device, the platelet-rich plasma and the blood coagulation agent are mixed in the spraying device to generate platelet-rich gel, and the platelet-rich gel is sprayed from the spraying device.
Owner:康膝生物医疗(深圳)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products